Immunotherapy drug for bladder cancer approved by FDA

Stephen Feller
BETHESDA, Md., May 19 (UPI) -- The FDA approved the drug Tecentriq for bladder cancer, making another drug that shrinks or kills tumors by helping the immune system fight cancer cells.